Filing Details
- Accession Number:
- 0001019687-13-001909
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-05-15 16:14:13
- Reporting Period:
- 2013-05-15
- Filing Date:
- 2013-05-15
- Accepted Time:
- 2013-05-15 16:14:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1172480 | Santarus Inc | SNTS | Pharmaceutical Preparations (2834) | 330734433 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1452697 | Ltd Technologies Cosmo | 42-43 Amiens St. Dublin, Ireland L2 1 | No | No | Yes | No | |
| 1452700 | S.p.a. Pharmaceuticals Cosmo | Via C. Colombo, 1 Lainate-Milano, Italy L6 20020 | No | No | No | Yes | |
| 1452701 | Mauro Ajani | Via C. Colombo, 1 Lainate-Milano, Italy L6 20020 | No | No | No | Yes | |
| 1452778 | Giuseppe Cipriano | Via C. Colombo, 1 Lainate-Milano, Italy L6 20020 | No | No | No | Yes | |
| 1452779 | Luigi Moro | Via C. Colombo, 1 Lainate-Milano, Italy L6 20020 | No | No | No | Yes | |
| 1452879 | S.p.a. Holding Cosmo | Piazza Della Repubblica, 3 Milano, Italy L6 20121 | No | No | No | Yes |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2013-05-15 | 4,887,500 | $17.68 | 2,991,044 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The complete price is $17.675125.
- These securities are owned directly by Cosmo Technologies Ltd., which is a wholly-owned subsidiary of Cosmo Pharmaceuticals S.p.A., which is a majority owned subsidiary of Cosmo Holding S.p.A. Cosmo Pharmaceuticals S.p.A. and Cosmo Holding S.p.A. may be deemed indirect beneficial owners of the reported securities. Messrs. Giuseppe Cipriano, Luigi Moro and Mauro Ajani may also be deemed to be indirect beneficial owners of the reported securities due to their relationship with these entities.
Billionaire Hedge Funds
